Search

Your search keyword '"Klarić , D"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Klarić , D" Remove constraint Author: "Klarić , D"
61 results on '"Klarić , D"'

Search Results

1. Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections

Catalog

Books, media, physical & digital resources

4. Mikroekstrakcija čvrstom fazom – inovativni pristup u bioanalitičkim istraživanjima.

6. Alport Spectrum Disorders in Croatia – Preliminary Results of First Genetic Testing in Croatia

7. SMJERNICE ZA PREVENCIJU, PRAĆENJE I LIJEČENJE POREMEĆAJA KOŠTANO-MINERALNOG METABOLIZMA U BOLESNIKA S KRONIČNOM BUBREŽNOM BOLESTI

8. Correlation of residual renal function with MIS score, nutritional status and cardiovascular risk factors in peritoneal dialysis patients: a Croatia nationwide multicentre study

9. Influence of nutritional status on anemia treatment in Croatian peritoneal dialysis patients

11. Characteristics of uncontrolled hypertensive patients. Results from the EH-UH study

12. Učestalost i klinički tijek pojedinih glomerulonefritisa u O.B.Zadar u periodu srpanj 2001-ožujak 2005

14. Treatment of anemia in chronic kidney disease - Position statement of the Croatian society for nephrology, dialysis and transplantation and review of the Kdigo and Erpb Guidelines | Liječenje anemije u kroničnoj bubrežnoj bolesti - Stav hrvatskog društva za nefrologiju, dijalizu i transplantaciju i osvrt na preporuke Kdigo i Erbp

15. Izazovi izvedbenog projekta postrojenja za separaciju sirove nafte i plina

16. The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics.

17. Radiolytic Elimination of Nabumetone from Aqueous Solution: Degradation Efficiency, and Degradants' Toxicity.

18. Biopharmaceutical Characterization and Stability of Nabumetone-Cyclodextrins Complexes Prepared by Grinding.

19. Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling.

20. McCleery Syndrome Caused by Pectoralis Minor Hypertrophy Treated with Multimodal Physical Therapy-A Case Report.

21. Product contamination during mechanochemical synthesis of praziquantel co-crystal, polymeric dispersion and cyclodextrin complex.

22. Crescentic Glomerulonephritis Due to Enterococcal Endocarditis.

23. Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease.

24. A Novel Approach for the Treatment of Aerobic Vaginitis: Azithromycin Liposomes-in-Chitosan Hydrogel.

25. Clinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population.

26. Determination of Curcuminoids, Piperine, Boswellic Acids and Andrographolides in Food and Dietary Supplements by HPLC.

27. Search for new antimicrobials: spectroscopic, spectrometric, and in vitro antimicrobial activity investigation of Ga(III) and Fe(III) complexes with aroylhydrazones.

28. Resistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab-A Case Report.

29. Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease.

30. Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy.

31. In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery.

32. Investigation of Praziquantel/Cyclodextrin Inclusion Complexation by NMR and LC-HRMS/MS: Mechanism, Solubility, Chemical Stability, and Degradation Products.

33. A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

34. Development of a HPLC-DAD stability-indicating method and compatibility study of azathioprine and folic acid as a prerequisite for a monolayer fixed-dose combination.

35. Drug-Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools.

36. A Comprehensive Approach to Compatibility Testing Using Chromatographic, Thermal and Spectroscopic Techniques: Evaluation of Potential for a Monolayer Fixed-Dose Combination of 6-Mercaptopurine and Folic Acid.

37. Physicochemical Compatibility Investigation of Mesalazine and Folic Acid Using Chromatographic and Thermoanalytical Techniques.

38. Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods.

39. Implementation of Venous Thromboembolism Prophylaxis Guidelines in Clinical Practice: A Retrospective Study in Two Croatian Hospitals.

40. Anemia Is Correlated with Malnutrition and Inflammation in Croatian Peritoneal Dialysis Patients: A Multicenter Nationwide Study.

41. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review.

42. Blood Pressure of Maintenance Hemodialysis Patients in the Dalmatian Region of Croatia: Differences between Hospital and Out-of-Hospital Dialysis Centers.

43. [END-STAGE RENAL DISEASE, DIALYSIS TREATMENT AND MANAGEMENT OF COMORBIDITY].

44. [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].

45. Evaluation of alcohol content and metal impurities in liquid dietary supplements by sHSS-GC-FID and GFAAS techniques.

46. [[GUIDELINES FOR THE PREVENTION, MONITORING AND THERAPY OF CHRONIC KIDNEY DISEASE-METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE].]

47. Blackberry wines mineral and heavy metal content determination after dry ashing: multivariate data analysis as a tool for fruit wine quality control.

48. [Croatian guidelines for screening, prevention and treatment of protein-energy wasting in chronic kidney disease patients].

49. [Transplantation and retransplantation--impact on emotional state].

50. [Assisted peritoneal dialysis].